Skip header and navigation
COVID-19 Rapid Evidence Reviews
  Refine Search

17 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
April 15, 2020 At what time in the disease timeline of COVID-19 do antibodies develop? LAB041402 RR Laboratory
April 11, 2020 Is the IgM or IgG immune response protective? LAB040803 RR Laboratory
October 29, 2021 Long COVID: What does it mean for the healthcare system and programs to deal with it? EOC021901v2 RR EOC
June 20, 2022 What are long COVID's demands on the healthcare system, and its severity of the illness? EPM210602v002 RR Epidemiology & Modelling
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
February 4, 2022 What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines? EOC220103 RR EOC
December 9, 2020 What are the predictors of mortality in hospitalized COVID-19 patients? CC120402 RR Critical Care
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
June 6, 2022 What is known about hybrid immunity to COVID-19? INF220501 RR Infectious Disease
September 29, 2020 What is the evidence that runny nose or sneezing are symptoms of COVID-19? EOC092401 RR EOC
February 27, 2021 What is the final disposition of post-COVID patients who require chronic ventilation in the ICU? CC011101 RR Critical Care
March 31, 2022 What is the incidence and duration of long COVID cases? EPM210601v2 RR Epidemiology & Modelling
April 7, 2020 What is the prevalence of sore throat as a symptom of COVID-19? EOC040201 RR EOC
May 19, 2020 What is the relationship between antibody development and viral shedding and infectiousness? [Update] LAB041601v2 RR Laboratory
November 2, 2020 What is the risk of reinfection from COVID-19? [Update] EOC032401v3 RR EOC
May 11, 2020 What percentage of COVID-19 patients have hyposmia or anosmia? EOC033102 RR EOC
May 8, 2020 What proportion of disease transmission is due to asymptomatic, pre-symptomatic and symptomatic cases? [Update] LAB040701v2 RR Laboratory

17 records – page 1 of 1.